Bellicum Pharmaceuticals, Inc
BLCM
Revenue
1.00M
▲1.00M∞%
3 Months ChangeAssets
6.85M
▼-1.88M▼-21.53%
3 Months ChangeLiabilities
2.25M
▼-1.23M▼-35.41%
3 Months ChangeFree Cash Flow
-6.44M
▼-51.00k▼-0.7989%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-02-23
Form 8-K
ID: 0001539497-24-000590
2024-02-21
Form 8-K
ID: 0001539497-24-000541
2024-01-30
Form 8-K
ID: 0001539497-24-000149
2024-01-24
Form 8-K
ID: 0001539497-24-000104
2023-12-14
Form 8-K
ID: 0001539497-23-002188
2023-11-22
Form 8-K
ID: 0001628280-23-039830
2023-11-14
Form 10-Q
ID: 0001628280-23-038953
2023-09-29
Form 8-K
ID: 0001628280-23-033257
2023-08-21
Form 8-K
ID: 0001628280-23-030016
2023-08-10
Form 10-Q
ID: 0001628280-23-028893